Cochlear introduces the new Osia® 3 Sound Processor

About this update from Cochlear Limited

LONE TREE, Colo., July 13, 2026 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announces FDA clearance of the new Cochlear ® Osia ® 3 Sound Processor the newest advancement of the award-winning Osia System.‡ Cochlear's bone conduction hearing solutions are designed to improve hearing outcomes for children and adults with conductive hearing loss, mixed hearing loss and single-sided deafness (SSD). The world's most chosen bone conduction system# is now even better. The Osia 3 Sound Processor builds on all the reasons tens of thousands have chosen the Osia System—its high-frequency Piezo Power™ performance, MRI compatibility at 1.5 and 3 T*, and demonstrated reliability1—while also adding: The Osia 3 Sound Processor is the first fully rechargeable sound processor in its class, providing up to 30 hours of hearing on a single charge.†, 7-9 It also features an on-the-go charging case that holds additional charges, similar to wireless earbuds. That means no more purchasing or handling disposable batteries, for less waste and greater convenience. Thanks to design changes, including the new lithium-ion battery, the most powerful active bone conduction system available4-6 now offers even more high-frequency power. These improvements enable the new frequency-specific fitting range with bone conduction thresholds up to 65 dB HL in the mid to high frequencies.¥ In clinical studies, patients with the Osia 3 Sound Processor have demonstrated improved speech understanding and preferred the sound quality over the previous generation.2,3 "I cannot do justice how much of an incredible transformation the Cochlear Osia System has been to me," Dr. Fred Wamboldt, Osia 3 System recipient said.

View stock analysis, news, and events for Cochlear Limited